Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies

RSV infection causes severe respiratory illness and mortality in the elderly, especially in the presence of comorbidities. Early identification of infection would result in appropriate clinical-therapeutic management, avoiding hospitalizations, the risk of healthcare-associated infections, and inapp...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca Centrone (Author), Daniela Loconsole (Author), Alfredo Marziani (Author), Valentina Annachiara Orlando (Author), Arianna delle Fontane (Author), Martina Minelli (Author), Maria Chironna (Author)
Format: Book
Published: MDPI AG, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_10f95d3a63d84f2cad71f8eaa8df061e
042 |a dc 
100 1 0 |a Francesca Centrone  |e author 
700 1 0 |a Daniela Loconsole  |e author 
700 1 0 |a Alfredo Marziani  |e author 
700 1 0 |a Valentina Annachiara Orlando  |e author 
700 1 0 |a Arianna delle Fontane  |e author 
700 1 0 |a Martina Minelli  |e author 
700 1 0 |a Maria Chironna  |e author 
245 0 0 |a Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies 
260 |b MDPI AG,   |c 2024-05-01T00:00:00Z. 
500 |a 10.3390/idr16030037 
500 |a 2036-7449 
520 |a RSV infection causes severe respiratory illness and mortality in the elderly, especially in the presence of comorbidities. Early identification of infection would result in appropriate clinical-therapeutic management, avoiding hospitalizations, the risk of healthcare-associated infections, and inappropriate antibiotic prescriptions, thus reducing healthcare costs and fighting antimicrobial resistance. The aim of this study was to assess RSV hospitalizations in subjects >64 years hospitalized in a large tertiary care hospital in Southern Italy, in order to assess their usefulness as a proxy for targeting a potential vaccination strategy. Fifty-two RSV-positive patients were identified from the 2014-2015 to the 2022-2023 seasons. RSV type B was found in 71.2% of cases. The median age was 78 years (IQR: 72-84) and 40.4% of the subjects had at least one comorbidity; 5.8% needed intensive care. The use of combined rapid tests for SARS-CoV-2/influenza/RSV identification in primary care settings may contribute to an improved definition of the burden of RSV in the elderly. The implementation of an anti-RSV vaccination strategy in the elderly population would reduce direct and indirect infection costs. More robust epidemiological data in Italy are needed for targeted preventive strategies. 
546 |a EN 
690 |a RSV infection 
690 |a viral infectious diseases 
690 |a elderly 
690 |a vaccination 
690 |a RSV vaccine 
690 |a hospitalization 
690 |a Other systems of medicine 
690 |a RZ201-999 
655 7 |a article  |2 local 
786 0 |n Infectious Disease Reports, Vol 16, Iss 3, Pp 491-498 (2024) 
787 0 |n https://www.mdpi.com/2036-7449/16/3/37 
787 0 |n https://doaj.org/toc/2036-7449 
856 4 1 |u https://doaj.org/article/10f95d3a63d84f2cad71f8eaa8df061e  |z Connect to this object online.